BRUKER CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
BRUKER CORPORATION (BRKR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$7.00M.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$11.50M, a 136.39% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$400.00K.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $17.70M.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $28.80M.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$111.60M.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$7.70M, a 135.32% decline from fiscal 2022.
- BRUKER CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $21.80M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.00M 10-Q · filed 2026-08-05 | -$18.50M 10-Q · filed 2026-08-05 | -$18.90M derived: sum of 3 quarters · filed 2026-08-05 | -$1.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$11.50M 10-Q · filed 2026-05-07 | -$11.90M derived: sum of 2 quarters · filed 2026-05-07 | $5.80M derived: sum of 3 quarters · filed 2026-05-07 | -$14.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.30M derived: sum of 2 quarters · filed 2026-02-27 | -$2.80M derived: sum of 3 quarters · filed 2026-08-05 | $28.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | $17.70M 10-Q · filed 2025-11-05 | -$2.40M derived: sum of 2 quarters · filed 2026-08-05 | $29.20M 10-Q · filed 2025-11-05 | -$14.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$20.10M 10-Q · filed 2026-08-05 | $11.50M 10-Q · filed 2026-08-05 | -$32.10M derived: sum of 3 quarters · filed 2026-08-05 | -$49.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $31.60M 10-Q · filed 2026-05-07 | -$12.00M derived: sum of 2 quarters · filed 2026-05-07 | -$29.00M derived: sum of 3 quarters · filed 2026-05-07 | -$65.50M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$43.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$60.60M derived: sum of 2 quarters · filed 2026-02-27 | -$97.10M derived: sum of 3 quarters · filed 2026-02-27 | -$111.60M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$17.00M 10-Q · filed 2025-11-05 | -$53.50M derived: sum of 2 quarters · filed 2025-11-05 | -$68.00M 10-Q · filed 2025-11-05 | -$55.30M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$36.50M 10-Q · filed 2025-08-06 | -$51.00M 10-Q · filed 2025-08-06 | -$38.30M derived: sum of 3 quarters · filed 2026-02-27 | -$69.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$14.50M 10-Q · filed 2025-05-07 | -$1.80M derived: sum of 2 quarters · filed 2026-02-27 | -$32.50M derived: sum of 3 quarters · filed 2026-02-27 | -$37.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$18.00M derived: sum of 2 quarters · filed 2026-02-27 | -$22.90M derived: sum of 3 quarters · filed 2026-02-27 | -$7.70M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$30.70M 10-Q · filed 2024-11-07 | -$35.60M derived: sum of 2 quarters · filed 2024-11-07 | -$20.40M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$4.90M 10-Q · filed 2024-08-09 | $10.30M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $15.20M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $21.80M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | -$11.90M 10-K · filed 2024-02-29 | |||
| 2016-03-31 | $32.40M 10-Q · filed 2016-05-06 | |||
| 2015-09-30 | -$7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$35.90M 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | -$28.00M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |